Notably absent is Ozempic, the drug that made GLP-1 medications a household name
More muscle means better glucose disposal and improved metabolic resilience
Int J Mol Sci (2019) 20:5407
It works by helping the body produce less glucose (sugar) from the food you eat and improving your bodys response to insulin
Structure Therapeutics is among the most advanced challengers, with its oral GLP-1 receptor agonist aleniglipron generating Phase 2 data that has drawn significant industry attention
Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)